INTRODUCTION: Recent findings reveal that the precursors of exhausted CD8(+) T (CD8(+) Tpex) cells possess stem-like signatures in tumor immunity, which originate from tumor draining lymph node (TdLN)-derived tumor-specific memory (CD8(+) T(TSM)) cells. Both of these T subsets can be collectively referred to as stem-like CD8(+) T cells, which demonstrate robust self-renewal ability and can proliferate and differentiate into transitory effector-like exhausted T cells (Tex(int)). There are reports that chemotherapeutic drugs can promote the antitumor immune responses of patients by increasing the number of CD8(+) T cells; however, whether chemotherapeutic drugs increase these two stem-like CD8(+) T cells remain further exploration. METHODS: Tpex cell-associated subpopulations in human colorectal tumors were analyzed by using single-cell sequencing data. CT26 and B16 tumor models of wild type and Eomes conditional knockout mice were constructed, and the changes of T(TSM), Tpex and Tex subsets in mice were dissected by flow cytometry after treatment with decitabine (DAC), doxorubicin (DOX) and 5-Fluorouracil (5-FU). RESULTS: In this study, we demonstrated that DAC and 5-FU expanded CD8(+) T(TSM) cells in TdLNs. At the same time, we validated that DAC and 5-FU substantially promoted the expansion of CD62L(+)CD8(+) Tpex cells and subsequently increased effector function of CX3CR1(+) CD8(+) Tex(int) cells. In addition, the conditional knockout of transcription factor Eomes in CD8(+) T cells partially eliminated DAC-amplified CD62L(+) CD8(+) Tpex cells, but had no effect on such CD8(+) T subset expanded by 5-FU. CONCLUSION: The present study demonstrated that both DAC and 5-FU promoted the differentiation of stem-like CD8(+) T(TSM) cells in TdLNs and significantly enhanced the differentiation and expansion of stem-like CD62L(+) CD8(+) Tpex and CX3CR1(+) Tex(int) cells in tumor microenvironment. The knockout of Eomes partially influenced the role of DAC in promoting the differentiation and expansion of stem-like CD8(+) T cells.
Two chemotherapeutic agents expand stem-like CD62L(+)CD8(+) T cells in antitumor immune responses.
两种化疗药物可扩增抗肿瘤免疫反应中的干细胞样 CD62L(+)CD8(+) T 细胞
阅读:5
作者:Ruan Xiaokang, Wu Linwei, Tang Zijian, Li Yao, Wang Jin, Jiang Haolin, Zhang Li, Wang Shengjia, Chen Zhaoqiang, Yuan Chenlei, Xia Yujian, Pan Yan, Gao Jianling, Zhao Xin
| 期刊: | Frontiers in Immunology | 影响因子: | 5.900 |
| 时间: | 2025 | 起止号: | 2025 Apr 1; 16:1533857 |
| doi: | 10.3389/fimmu.2025.1533857 | 靶点: | CD8 |
| 研究方向: | 肿瘤 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
